Correction for Fox, Circulation 104 (21) e9051-e9052.

This Article Extract Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

(Circulation. 2002;105:e9064.)
© 2002 American Heart Association, Inc.

Cardiovascular News

In the Cardiovascular News article, "American Heart Association 2001 Scientific Sessions: Late-Breaking Science," by Robin Fox that appeared in the November 20, 2001, issue of the journal (Circulation. 2001;104:e9051), an error appeared. The fourth sentence from the end of the first paragraph read: "When allowance is made for noncompliance and treatment changes during the trial, Collins concludes that simvastatin reduced these major vascular events by at least one third in a wide range of high-risk patients for whom the indication for cholesterol-lowering therapy had been uncertain—notably, women, people >70 years of age, and people with an LDL cholesterol level <200 mg/dL (3 mmol/L)."

The value "200 mg/dL" was incorrect. The corrected sentence follows:

"When allowance is made for noncompliance and treatment changes during the trial, Collins concludes that simvastatin reduced these major vascular events by at least one third in a wide range of high-risk patients for whom the indication for cholesterol-lowering therapy had been uncertain—notably, women, people >70 years of age, and people with an LDL cholesterol level <120 mg/dL (3 mmol/L)."

This Article Extract Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content